  | Sakalihasan, N., Brüls, S., Hustinx, R., Tchana-Sato, V., SAKALIHASAN, S., Hultgren, R., Labropoulos, N., Colige, A., Durieux, R., Drion, P., Albert, A., Defraigne, J.-O., & MUSUMECI, L. (09 March 2024). Association between PET/CT Scan Findings, Treatment, and Cancer Incidence in a Cohort of AAA Patients. Journal of Clinical Medicine, 13 (6), 1569. doi:10.3390/jcm13061569  Peer Reviewed verified by ORBi |
  | Pincemail, J.* , Tchana-Sato, V.* , Courtois, A., MUSUMECI, L., CHERAMY-BIEN, J.-P., Munten, J., Labropoulos, N., Defraigne, J.-O., & Sakalihasan, N. (16 May 2023). Alteration of Blood Oxidative Stress Status in Patients with Thoracic Aortic Dissection: A Pilot Study. Antioxidants, 12 (5), 1106. doi:10.3390/antiox12051106 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Lancellotti, P., Aqil, A., MUSUMECI, L., Jacques, N., Ditkowski, B., Debuisson, M., Thiry, M., Dupont, J., Gougnard, A., Sandersen, C., CHERAMY-BIEN, J.-P., Sakalihasan, N., Nchimi Longang, A., Detrembleur, C., Jérôme, C., & Oury, C. (2023). Bioactive surface coating for preventing mechanical heart valve thrombosis. Journal of Thrombosis and Haemostasis. doi:10.1016/j.jtha.2023.05.004 Peer reviewed |
 | Oury, C., Meyers, S., Jacques, N., Leeten, K., Jiang, Z., MUSUMECI, L., Lox, M., Debuisson, M., Goffin, E., Pirotte, B., Delvenne, P., Nchimi Longang, A., Hubert, C., Heptia, M., Hubert, P., Kuijpers, M. J. E., Vanassche, T., Martinod, K., Verhamme, P., & Lancellotti, P. (2023). Protective Effect of Ticagrelor Against Infective Endocarditis Induced by Virulent Staphylococcus aureus in Mice. JACC: Basic to Translational Science. doi:10.1016/j.jacbts.2023.02.003 Peer Reviewed verified by ORBi |
 | MUSUMECI, L., Eilenberg, W., Pincemail, J., Yoshimura, K., & Sakalihasan, N. (29 November 2022). Towards Precritical Medical Therapy of the Abdominal Aortic Aneurysm. Biomedicines, 10 (12), 3066. doi:10.3390/biomedicines10123066 Peer Reviewed verified by ORBi |
 | LANCELLOTTI, P., Oury, C., Pirotte, B., MUSUMECI, L., Jacques, N., & Goffin, E. (23 September 2021). Preparation of pyrimidine derivatives for prevention and treatment of Gram-negative bacterial infection, contamination and fouling. |
 | Oury, C., Pirotte, B., MUSUMECI, L., Jacques, N., Goffin, E., & LANCELLOTTI, P. (22 October 2020). New pyrimidine derivatives for prevention and treatment of gram negative bacterial infection, contamination and fouling. |
 | Goffin, E., Jacques, N., Musumeci, L., Nchimi Longang, A., Oury, C., Lancellotti, P., & Pirotte, B. (2020). Synthesis of ticagrelor analogues belonging to 1,2,3-triazolo[4,5-d]pyrimidines and study of their antiplatelet and antibacterial activity. European Journal of Medicinal Chemistry, 208, 112767. doi:10.1016/j.ejmech.2020.112767 Peer Reviewed verified by ORBi |
 | Musumeci, L., Oury, C., & Lancellotti, P. (2020). When your heart depends on your gut feelings. Revista Española de Cardiología (English Edition). doi:10.1016/j.rec.2020.03.006 Peer Reviewed verified by ORBi |
 | Lancellotti, P., Musumeci, L., & Oury, C. (2019). Are Antiplatelet Agents Beneficial in Prevention of Infective Endocarditis?-Reply. JAMA Cardiology. doi:10.1001/jamacardio.2019.3089 Peer Reviewed verified by ORBi |
 | Lancellotti, P., Musumeci, L., Jacques, N., Servais, L., Goffin, E., Pirotte, B., & Oury, C. (2019). Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria. JAMA Cardiology. doi:10.1001/jamacardio.2019.1189 Peer Reviewed verified by ORBi |
| Oury, C., Musumeci, L., Jacques, N., & LANCELLOTTI, P. (2019). Activité antibiotique de l'antiplaquettaire ticagrelor : une nouvelle piste contre l'antibiorésistance. Vaisseaux, Coeur, Poumons, 24 (7), 8-13. Peer reviewed |
 | Musumeci, L., Jacques, N., Hego, A., Nchimi Longang, A., Lancellotti, P., & Oury, C. (2018). Prosthetic Aortic Valves: Challenges and Solutions. Frontiers in Cardiovascular Medicine, 5, 46. doi:10.3389/fcvm.2018.00046 Peer Reviewed verified by ORBi |
 | Delierneux, C., Donis, N., Servais, L., Wéra, O., LECUT, C., Vandereyken, M., Musumeci, L., Rahmouni, S., Schneider, J., Eble, J., LANCELLOTTI, P., & Oury, C. (May 2017). Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides. Journal of Thrombosis and Haemostasis, 15 (5), 983-997. doi:10.1111/jth.13669 Peer Reviewed verified by ORBi |
 | Vandereyken, M., Singh, P., Wathieu, C., Jacques, S., Zurashvili, T., Dejager, L., Amand, M., Musumeci, L., Singh, M., MOUTSCHEN, M., Libert, C., & Rahmouni, S. (2017). Dual-Specificity Phosphatase Deletion Protects Female, but Not Male, Mice from Endotoxemia- and Polymicrobial-Induced Septic Shock. Journal of Immunology. doi:10.4049/jimmunol.1602092 Peer Reviewed verified by ORBi |
 | Dubois, N., Willems, M., Kroonen, J., Berendsen, S., Van Hecke, W., Bredel, M., Musumeci, L., Poulet, C., Chakravarti, A., Bours, V., & Robe, P. (09 September 2016). Involvement of Ikbζ in glioblastomas and its potential implication in radioresistance [Poster presentation]. Annual Mini Symposium - EDT-Cancérologie Expérimentale, Bruxelles, Belgium. |
 | Rahmouni, S., Hego, A., Delierneux, C., Wéra, O., Musumeci, L., Tautz, L., & Oury, C. (2016). Functional analysis of protein tyrosine phosphatases in thrombosis and haemostasis. In Protein Tyrosine Phosphatases: Methods and Protocols (pp. 301-30). New York, United States: Springer Science. Peer reviewed |
 | Dubois, N., Willems, M., Kroonen, J., Berendsen, S., Van Hecke, W., Bredel, M., Musumeci, L., Poulet, C., Chakravarti, A., Bours, V., & Robe, P. (2016). Involvement of Ikbζ in glioblastomas and its potential implication in radioresistance [Poster presentation]. 28th EORTC-NCI-AACR symposium on "Molecular targets and cancer therapeutics", Munich, Germany. |
 | Willems, M., Dubois, N., Musumeci, L., Bours, V., & Robe, P. (2016). IkappaBzeta: an emerging player in cancer. Oncotarget, 7 (40), 66310-66322. doi:10.18632/oncotarget.11624 Peer Reviewed verified by ORBi |
| Rahmouni, S., MUSUMECI, L., Kuijpers, M. J., Gilio, K., Hego, A., Theatre, E., Senis, Y., Heemskerk, J., Thiry, M., Tautz, L., & Oury, C. (24 June 2015). DUSP3 Phosphatase Deficiency or Inhibition Limits Platelet Activation and Arterial Thrombosis [Paper presentation]. ISTH 2015 Congress, Toronto, Canada. |
| Delierneux, C., Hego, A., LECUT, C., Vandereyken, M., MUSUMECI, L., Rahmouni, S., BOURS, V., Lancellotti, P., & Oury, C. (22 June 2015). CLEC-2 is required for the activation of mouse platelets by bacterial DNA mimetics [Paper presentation]. ISTH 2015 Congress, Toronto, Canada. |
| Delierneux, C., Hego, A., LECUT, C., Vandereyken, M., MUSUMECI, L., Rahmouni, S., BOURS, V., LANCELLOTTI, P., & Oury, C. (22 June 2015). CLEC-2 is required for the activation of mouseplatelets by bacterial DNA mimetics [Paper presentation]. ISTH 2015 Congress, Toronto, Canada. |
 | Singh, P.* , Dejager, L.* , Amand, M.* , Theatre, E., Vandereyken, M., Zurashvili, T., Singh, M., Mack, M., Timmermans, S., Musumeci, L., Dejardin, E., Mustelin, T., Van Ginderachter, J. A., Moutschen, M., Oury, C., Libert, C., & Rahmouni, S. (15 May 2015). DUSP3 genetic deletion confers M2-like−macrophage-dependent tolerance to septic shock. Journal of Immunology, 194 (10), 4951-62. doi:10.4049/jimmunol.1402431 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Musumeci, L., Kuijpers, M., Gilio, K., Hego, A., Theatre, E., Maurissen, L., Vandereyken, M., Diogo, C., LECUT, C., Guilmain, W., Bobkova, E., Eble, J., Dahl, R., Drion, P., Rascon, J., Mostofi, Y., Yuan, H., Sergienko, E., Chung, T., ... Rahmouni, S.*. (17 February 2015). DUSP3 Phosphatase Deficiency or Inhibition Limit Platelet Activation and Arterial Thrombosis. Circulation, 131 (7), 656-68. doi:10.1161/CIRCULATIONAHA.114.010186 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Delierneux, C., Hego, A., LECUT, C., Vandereyken, M., Musumeci, L., Rahmouni, S., Thiry, M., Compère, P., BOURS, V., Lancellotti, P., & Oury, C. (27 January 2015). Bacterial DNA mimetics activate platelets and promote thrombosis via CLEC-2 [Poster presentation]. GIGA-DAY: Current advances in medical genetics and genomics, Liège, Belgium. |
 | Amand, M., Erpicum, C., BAJOU, K., Cerignoli, F., Blacher, S., MARTIN, M., Dequiedt, F., Drion, P., Singh, P., Vandereyken, M., Musumeci, L., Moutschen, M., Gilles, C., Noël, A., & Rahmouni, S. (27 January 2014). DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase [Poster presentation]. GIGA Day 2014, Liège, Belgium. |
 | Amand, M., Erpicum, C., BAJOU, K., Cerignoli, F., Blacher, S., Martin, M., Dequiedt, F., Drion, P., Singh, P., Zurashvili, T., Vandereyken, M., Musumeci, L., Mustelin, T., Moutschen, M., Gilles, C., Noël, A., & Rahmouni, S. (2014). DUSP3/VHR is a pro-angiogenic atypical dual-specificity phosphatase. Molecular Cancer. doi:10.1186/1476-4598-13-108 Peer Reviewed verified by ORBi |
 | Musumeci, L., Maurissen, L., Kuijpers, M. J., Senis, Y., MOUTSCHEN, M., Mustelin, T., Heemskerk, J. W., Oury, C., & Rahmouni, S. (02 July 2013). Genetic deletion of Vaccinia H1-related (VHR) phosphatase inhibits collagen-induced platelet activation and thrombus formation without affecting bleeding time in mice [Paper presentation]. XXIVth Congress of the ISTH, Amsterdam, Netherlands. |
 | Rahmouni, S., Singh, P., Dejager, L., Singh, M., Amand, M., Musumeci, L., Moutschen, M., Mustelin, T., & Libert, C. (2013). Dual-specificity phosphatase 3 knockout female mice are resistant to LPS and to polymicrobial induced septic shock in TNF dependent manner. Journal of Immunology. Peer Reviewed verified by ORBi |
 | Tautz, L., Vang, T., Liu, W., Delacroix, L., Wu, S., Vasile, S., Dahl, R., Yang, L., MUSUMECI, L., Francis, D., Landskron, J., Tasken, K., Tremblay, M., Lie, B., Page, R., Mustelin, T., Rahmouni, S., & Rickert, R. (April 2012). Dynamic interaction between lymphoid tyrosine phosphatase and C-terminal Src kinase controls T cell activation. FASEB Journal, 26. Peer Reviewed verified by ORBi |
 | Singh, M., Singh, P., Gaudray, G., Musumeci, L., Thielen, C., VAIRA, D., Vandergeeten, C., Delacroix, L., Van Gulck, E., Vanham, G., de Leval, L., Rahmouni, S., & MOUTSCHEN, M. (2012). An improved protocol for efficient engraftment in NOD/LTSZ-SCIDIL-2Rgammanull mice allows HIV replication and development of anti-HIV immune responses. PLoS ONE, 7 (6), 38491. doi:10.1371/journal.pone.0038491 Peer Reviewed verified by ORBi |
 | Vang, Liu, W. H., Delacroix, L., Wu, S., Vasile, S., Dahl, R., Yang, L., Musumeci, L., Francis, D., Landskron, J., Tasken, T., Tremblay, M. L., Lie, B. A., Page, R., Mustelin, T., Rahmouni, S., Rickert, R. C., & Tautz, L. (2012). LYP inhibits T-cell activation when dissociated from CSK. Nature Chemical Biology. doi:10.1038/nchembio.916 Peer Reviewed verified by ORBi |
 | Musumeci, L., Arthur, J., Cheung, F., Hoque, A., Lippman, S., & Reichardt, J. (January 2010). Single nucleotide differences (SNDs) in the dbSNP database may lead to errors in genotyping and haplotyping studies. Human Mutation, 31 (1), 63-73. doi:10.1002/humu.21137 Peer Reviewed verified by ORBi |
 | Musumeci, L., Bongiorni, C., Tautz, L., Edwards, R., Osterman, A., Perego, M., Mustelin, T., & Bottini, N. (July 2005). Low-Molecular-Weight Protein Tyrosine Phosphatases of Bacillus subtilis. Journal of Bacteriology, 187 (14), 4945-4956. doi:10.1128/JB.187.14.4945-4956.2005 Peer Reviewed verified by ORBi |
 | Mijakovic, I., Musumeci, L., Tautz, L., Petranovic, D., Edwards, R., Jensen, P. R., Mustelin, T., Deutscher, J., & Bottini, N. (May 2005). In vitro characterization of the Bacillus subtilis protein tyrosine phosphatase YwqE. Journal of Bacteriology, 187 (10), 3384-90. doi:10.1128/JB.187.10.3384-3390.2005 Peer Reviewed verified by ORBi |
 | Vang, T., Congia, M., Macis, M. D., Musumeci, L., Orru, V., Zavattari, P., Nika, K., Tautz, L., Tasken, K., Cucca, F., Mustelin, T., & Bottini, N. (2005). Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nature Genetics, 37 (12), 1317-9. doi:10.1038/ng1673 Peer Reviewed verified by ORBi |
 | Bottini, N., Musumeci, L., Alonso, A., Rahmouni, S., Nika, K., Rostamkhani, M., MacMurray, J., Meloni, G. F., Lucarelli, P., Pellecchia, M., Eisenbarth, G. S., Comings, D., & Mustelin, T. (2004). A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nature Genetics, 36 (4), 337-8. doi:10.1038/ng1323 Peer Reviewed verified by ORBi |
 | Huynh, H., Bottini, N., Williams, S., Cherepanov, V., Musumeci, L., Saito, K., Bruckner, S., Vachon, E., Wang, X., Kruger, J., Chow, C.-W., Pellecchia, M., Monosov, E., Greer, P. A., Trimble, W., Downey, G. P., & Mustelin, T. (2004). Control of vesicle fusion by a tyrosine phosphatase. Nature Cell Biology, 6 (9), 831-9. doi:10.1038/ncb1164 Peer Reviewed verified by ORBi |
 | Junqueira, D.* , Cilenti, L.* , Musumeci, L., Sedivy, J., & Zervos, A. (January 2003). Random mutagenesis of PDZOmi domain and selection of mutants that specifically bind the Myc proto-oncogene and induce apoptosis. Oncogene, 22, 2772–2781. doi:10.1038/sj.onc.1206359 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |